Skip to main content
. 2019 Oct 10;134(24):2127–2138. doi: 10.1182/blood.2019001869

Figure 2.

Figure 2.

Participant disposition. All participants received the same loading dose of emicizumab 3 mg/kg per week for 4 weeks. *Participant discontinued study treatment due to ADAs with neutralizing potential and subsequent lack of efficacy following a dose uptitration to 3 mg/kg per week (starting at week 9) and remained on study for safety follow-up.